Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Viets, Henry R.
1966.
INTRODUCTORY REMARKS.
Annals of the New York Academy of Sciences,
Vol. 135,
Issue. 1,
p.
5.
Pascuzzi, Robert M.
1994.
The History of Myasthenia Gravis.
Neurologic Clinics,
Vol. 12,
Issue. 2,
p.
231.
Keeney, Arthur H.
and
Keeney, Virginia T.
1997.
Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.
Documenta Ophthalmologica,
Vol. 93,
Issue. 1-2,
p.
125.
CUNHA, FRANCISCO MARCOS B.
SCOLA, ROSANA HERMÍNIA
and
WERNECK, LINEU CÉSAR
1999.
Miastenia grave: aspectos históricos.
Arquivos de Neuro-Psiquiatria,
Vol. 57,
Issue. 2B,
p.
531.
Robinson, Brian
2002.
Syntheses of (-)-Physostigmine, with Particular Emphasis upon the Clarification of Two Enigmatic Early Synthetic Approaches.
HETEROCYCLES,
Vol. 57,
Issue. 7,
p.
1327.
Ball, C.
and
Westhorpe, R. N.
2006.
Muscle Relaxants—Reversal Agents.
Anaesthesia and Intensive Care,
Vol. 34,
Issue. 4,
p.
415.
Lee, M R
2007.
The miracle at St Alfege's: seventy years on.
Journal of the Royal Society of Medicine,
Vol. 100,
Issue. 2,
p.
108.
Ohry, Avi
2009.
Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis.
Journal of Medical Biography,
Vol. 17,
Issue. 2,
p.
73.
Feibel, Robert M.
2021.
Henry R. Viets, MD, and the History of Myasthenia Gravis.
Neurology,
Vol. 96,
Issue. 7,
p.
322.
Katz, Natalie K.
and
Barohn, Richard J.
2021.
The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis.
Neuropharmacology,
Vol. 182,
Issue. ,
p.
108303.
Robinson, Brian
2023.
The Calabar Bean and its Alkaloids.
p.
169.
Giannis, Athanassios
2023.
Naturstoffe im Dienst der Medizin - Von der Tragödie zur Therapie.
p.
21.
Weatherall, Mark
2024.
Walker's miracle of science.
The Lancet Neurology,
Vol. 23,
Issue. 1,
p.
34.